Vivimed Labs Limited [VIVIMEDLAB] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Vivimed Labs Limited

NSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vivimed Labs Limited wins in 6 metrics, Gujarat Themis Biosyn Ltd. wins in 12 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vivimed Labs Limited Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) -1.74 73.73 Gujarat Themis Biosyn Ltd.
Price-to-Book Ratio -1.16 13.36 Gujarat Themis Biosyn Ltd.
Debt-to-Equity Ratio -8.01 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio -0.01 -17.55 Vivimed Labs Limited
EV/EBITDA -46.90 52.76 Gujarat Themis Biosyn Ltd.
Profit Margin (TTM) -39.54% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) -97.25% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) N/A 40.16% N/A
Return on Equity 90.88% 19.64% Vivimed Labs Limited
Return on Assets (TTM) -3.47% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-62.82M $-251.22M Vivimed Labs Limited
Dividend Yield N/A 0.17% N/A
1-Year Return 35.76% 31.69% Vivimed Labs Limited
Price-to-Sales Ratio (TTM) 0.64 22.23 Vivimed Labs Limited
Enterprise Value $4.40B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 4.98 22.65 Vivimed Labs Limited
Gross Profit Margin (TTM) 50.60% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $11 $15 Gujarat Themis Biosyn Ltd.
Earnings per Share (Diluted) $-4.21 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 0.74 -0.17 Gujarat Themis Biosyn Ltd.

Vivimed Labs Limited vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

VIVIMEDLAB
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vivimed Labs Limited-0.93%-0.93%-7.79%-7.79%29.09%-61.94%
Gujarat Themis Biosyn Ltd.1.72%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vivimed Labs Limited35.76%16.87%-77.60%-91.57%-88.66%-81.43%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Vivimed Labs Limited vs Gujarat Themis Biosyn Ltd.

MetricVIVIMEDLABGUJTHEM
Market Information
Market Cap i₹556.35M₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i139,79179,452
90 Day Avg. Volume i155,662106,446
Last Close₹6.39₹401.80
52 Week Range₹4.95 - ₹29.40₹225.05 - ₹479.00
% from 52W High-78.27%-16.12%
All-Time High₹248.80 (Apr 24, 2006)₹479.00 (Oct 27, 2025)
% from All-Time High-97.43%-16.12%
Growth Metrics
Quarterly Revenue Growth-0.56%0.10%
Quarterly Earnings Growth-0.56%-0.04%
Financial Health
Profit Margin (TTM) i-0.40%0.30%
Operating Margin (TTM) i-0.97%0.40%
Return on Equity (TTM) i0.91%0.20%
Debt to Equity (MRQ) i-8.0127.04
Cash & Liquidity
Book Value per Share (MRQ)₹-5.78₹24.29
Cash per Share (MRQ)₹0.12₹0.92
Operating Cash Flow (TTM) i₹-172,560,000₹970.68M
Levered Free Cash Flow (TTM) i₹-319,610,000₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend i₹0.00₹0.67

Valuation & Enterprise Metrics Analysis: Vivimed Labs Limited vs Gujarat Themis Biosyn Ltd.

MetricVIVIMEDLAB (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-1.7473.73
Forward P/E iN/AN/A
PEG Ratio i-0.01-17.55
Price to Sales (TTM) i0.6422.23
Price to Book (MRQ) i-1.1613.36
Market Capitalization
Market Capitalization i₹556.35M₹35.41B
Enterprise Value i₹4.40B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i4.9822.65
Enterprise to EBITDA i-46.9052.76
Risk & Other Metrics
Beta i0.74-0.17
Book Value per Share (MRQ) i₹-5.78₹24.29

Financial Statements Comparison: Vivimed Labs Limited vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVIVIMEDLAB (2025)GUJTHEM (2025)
Revenue/Sales i1.16B1.51B
Cost of Goods Sold i636.23M318.78M
COGS % of Revenue i54.7%21.1%
Gross Profit i526.46M1.19B
Gross Margin i45.3%78.9%
Research & Development i4.22M34.37M
Operating Income (EBIT) i-290.03M642.49M
Operating Margin i-24.9%42.6%
EBITDA i-98.87M713.04M
EBITDA Margin i-8.5%47.3%
Pre-Tax Income i-318.48M655.38M
Pre-Tax Income % of Revenue i-27.4%43.5%
Income Tax i1.13M167.66M
Income Tax % of Revenue i0.1%11.1%
Net Income (Profit) i-319.61M487.72M
Profit Margin i-27.5%32.3%

Balance Sheet & Liquidity Metrics

MetricVIVIMEDLAB (2025)GUJTHEM (2025)
Cash & Equivalents i7.08M116.94M
Total Current Assets i3.28B519.73M
Total Current Assets % of Revenue i281.7%34.5%
Total Current Liabilities i4.08B205.60M
Total Current Liabilities % of Revenue i351.1%13.6%
Long-Term Debt i636.15M296.36M
Long-Term Debt % of Revenue i54.7%19.7%
Total Shareholders Equity i-351.69M2.48B
Retained Earnings i-3.22B2.37B
Retained Earnings % of Revenue i-277.2%157.4%
Property, Plant & Equipment i340.80M411.30M

Cash Flow Statement Comparison

MetricVIVIMEDLAB (2025)GUJTHEM (2025)
Operating Cash Flow i-172.56M970.68M
Operating Cash Flow % of Revenue i-14.8%64.4%
Capital Expenditures i-45.31M-1.16B
Free Cash Flow i-62.82M-251.22M
FCF Margin i-5.4%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVIVIMEDLABGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i82.91M108.97M
Float Shares i64.55M29.52M
% Held by Insiders i16.75%71.98%
% Held by Institutions i10.84%1.18%
% Held by Public i72.41%26.84%

Dividend Analysis & Yield Comparison: Vivimed Labs Limited vs Gujarat Themis Biosyn Ltd.

MetricVIVIMEDLABGUJTHEM
Last 12-Month Dividend i₹0.00₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend i₹0.00₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends i₹0.00₹0.67
Ex-Dividend DateN/ASep 04, 2025